Projects per year
Abstract
Background: Evidence is accumulating globally on harms from extramedical prescription opioid analgesic (POA) use. Objective: The aim of this scoping review was to explore harms and documented risk factors associated with extramedical POA use in Australia. Methods: MEDLINE, EMBASE, PsycINFO and CINAHL were searched for original studies published between January 2000 and February 2018. Studies were eligible for inclusion if: 1) POA use was explicitly reported, 2) extramedical use was evident 3) harm was explicitly reported, 4) data were collected in/after 2000, 5) conducted in adults and 6) undertaken in Australia. Results: We identified 560 articles and 16 met the inclusion criteria. Harms reported from extramedical POA use included: increased health service utilization (n = 5), non-fatal overdose (n = 6), fatal overdose (n = 5), injection-related injuries or diseases (n = 4), engagement in crime (n = 2), loss of employment (n = 1), and foreign body pulmonary embolization (n = 1). Multiple drug toxicity was reported as the cause of death in up to 83% of fatal overdose cases. Risk factors for harm included being male, aged 31–49 years, a history of chronic non-cancer pain, mental health disorders and/or substance abuse, and concomitant use of benzodiazepines, antidepressants or other centrally-acting substances. Conclusion: Extramedical use of POAs is associated with a range of harms, including fatal and non-fatal overdose. Polysubstance use with other centrally-acting substances was often implicated. No published studies used linked data sources to provide a comprehensive overview of the extent of POA use or harm in Australia. Future research should focus on undertaking longitudinal cohort studies with linked data sources.
Original language | English |
---|---|
Pages (from-to) | 925-935 |
Number of pages | 11 |
Journal | Research in Social and Administrative Pharmacy |
Volume | 15 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2019 |
Keywords
- Australia
- Drug overdose
- Extramedical use
- Harm
- Opioid analgesics
- Review
Projects
- 2 Finished
-
Optimising medicine regimens for people with dementia: maintaining function, maximising quality of life and preventing adverse events
Bell, S. (Primary Chief Investigator (PCI))
1/09/17 → 31/08/22
Project: Research
-
How therapeutic treatment pathways impact medicine safety and effectiveness
Ilomaki, J. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
2/03/14 → 1/03/19
Project: Research